ST
JUNO

Spot Trading’s Juno Therapeutics, Inc. JUNO Stock Holding History

Spot Trading’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$453K Buy
10,100
+7,200
+248% +$245K 0.01% 1721
2017
Q2 		$87K Buy
2,900
+1,900
+190% +$46.9K ﹤0.01% 2649
2017
Q1 		$22K Sell
1,000
-5,500
-85% -$118K ﹤0.01% 2657
2016
Q4 		$123K Sell
6,500
-7,900
-55% -$193K ﹤0.01% 2134
2016
Q3 		$432K Sell
14,400
-32,900
-70% -$1.02M 0.01% 1608
2016
Q2 		$1.82M Buy
47,300
+7,800
+20% +$324K 0.03% 754
2016
Q1 		$1.5M Buy
39,500
+15,900
+67% +$554K 0.03% 861
2015
Q4 		$1.04M Sell
23,600
-18,400
-44% -$913K 0.01% 1420
2015
Q3 		$1.71M Buy
42,000
+31,600
+304% +$1.39M 0.02% 1195
2015
Q2 		$555K Buy
+10,400
New +$552K 0.01% 2043

Other funds holding JUNO

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Spot Trading's JUNO Position: Q3 2017 in Review

Spot Trading increased its Juno Therapeutics, Inc. (JUNO) stake by 218% in Q3 2017, buying an estimated $714K and bringing the position to 30,565 shares worth $1.37M. The position accounts for 0.02% of the portfolio, ranked #957.

Spot Trading first reported a position in JUNO in Q2 2015 and has held it in 6 quarters since. 210 funds tracked by Wall St. Rank hold JUNO as of Q3 2017.

  • Spot Trading held 30,565 shares of Juno Therapeutics, Inc. worth $1.37M as of Q3 2017.
  • Spot Trading bought 20,945 Juno Therapeutics, Inc. shares in Q3 2017, an estimated $714K.
  • Juno Therapeutics, Inc. made up 0.02% of Spot Trading's portfolio in Q3 2017, its #957 holding.
  • Spot Trading first reported a position in Juno Therapeutics, Inc. in Q2 2015 and has held it in 6 quarters since.
  • 210 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.